Next-Generation Traumatic Brain Injury Treatment System

Publication ID: 24-11857801_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Traumatic Brain Injury Treatment System,” Published Technical Disclosure No. 24-11857801_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857801_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,801.

Summary of the Inventive Concept

A wearable, implantable, or injectable neural treatment system that utilizes adaptive, personalized near-infrared light therapy to revolutionize traumatic brain injury treatment, providing real-time brain activity feedback and bio-harvested energy powering.

Background and Problem Solved

The original patent addressed the need for effective traumatic brain injury treatment, but its limitations in terms of invasiveness, portability, and adaptability necessitate a next-generation solution. The new inventive concept tackles these limitations by integrating advanced technologies to provide a more targeted, efficient, and patient-centric treatment approach.

Detailed Description of the Inventive Concept

The next-generation traumatic brain injury treatment system consists of a wearable, implantable, or injectable device that delivers targeted, adaptive, and personalized near-infrared light therapy to specific brain regions. The device is powered by a bio-harvested energy source, ensuring a sustainable and self-sufficient operation. The system combines near-infrared light therapy with artificial intelligence-driven brain stimulation and cognitive training, and is connected to a cloud-based platform for remote monitoring and personalized treatment planning. The device is capable of real-time neural signal processing and adaptive therapy adjustment, utilizing machine learning algorithms to identify and predict individualized treatment responses.

Novelty and Inventive Step

The new inventive concept's novelty lies in its integration of advanced technologies, including bio-harvested energy powering, artificial intelligence-driven brain stimulation, and machine learning-based treatment response prediction. The inventive step resides in the system's ability to provide real-time brain activity feedback, adaptive therapy adjustment, and personalized treatment planning, making it a paradigm shift in traumatic brain injury treatment.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type of energy harvesting, using different wavelengths of light, or incorporating additional sensors to monitor other physiological parameters. Variations could also involve different form factors, such as a handheld device or a implantable chip, to cater to diverse patient needs and preferences.

Potential Commercial Applications and Market

The next-generation traumatic brain injury treatment system has vast commercial potential in the medical device industry, with target markets including hospitals, clinics, and rehabilitation centers. The system's portability, non-invasiveness, and adaptability make it an attractive solution for patients and healthcare providers, offering a significant improvement over existing treatment options.

Field of Art

Biomedical engineering, neural treatment technologies, specifically focused on traumatic brain injury (TBI) interventions using photobiomodulation and neural stimulation devices

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or neurotechnology researcher with expertise in medical device design, photobiomodulation techniques, neural interface technologies, and experience with light-based therapeutic interventions for neurological conditions

Obviousness Rationale

A person of ordinary skill would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core technology by applying known techniques in neural treatment, energy harvesting, and adaptive medical device design. The fundamental approach of using targeted light therapy for brain injury treatment remains consistent, with the PTD introducing incremental technological improvements that would be apparent to a skilled practitioner familiar with emerging neurotechnology trends.

Obvious Combinations & Variations

Source Patent Element
LED light array positioned within a headpiece for targeted brain injury treatment
PTD Variation
Expanding LED light array to include near-infrared wavelengths with AI-driven adaptive therapy protocols
Obviousness Reasoning
Selection of specific light wavelengths and incorporating adaptive control mechanisms would be a predictable design optimization for a skilled practitioner seeking enhanced therapeutic precision
Source Patent Element
Housing with inner surface configured for light array positioning
PTD Variation
Developing wearable, implantable, and injectable device form factors with integrated neural signal processing
Obviousness Reasoning
Modifying device form factor represents a routine design choice with predictable engineering solutions for expanding treatment modalities
Source Patent Element
Light-based neural treatment system with tubular light assemblies
PTD Variation
Integrating bio-harvested energy sources and machine learning-based treatment response prediction
Obviousness Reasoning
Incorporating energy harvesting and adaptive algorithms represents a logical technological progression using known techniques in medical device design
Source Patent Element
Tension components for positioning LED light assemblies
PTD Variation
Developing flexible, biocompatible substrates with integrated neural signal sensors and microprocessors
Obviousness Reasoning
Enhancing device structural flexibility and adding computational capabilities would be an obvious technological evolution for a skilled practitioner
Source Patent Element
Treatment system targeting traumatic brain injury
PTD Variation
Cloud-connected platform for remote monitoring and personalized treatment planning
Obviousness Reasoning
Implementing networked medical device technologies with data-driven personalization represents a standard technological advancement in medical device design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857801 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as the disclosed innovations represent predictable technological extensions employing known techniques in neural treatment device design, with no invention rising above the level of ordinary engineering skill in the field of traumatic brain injury interventions.

Original Patent Information

Patent NumberUS 11,857,801
TitleDevice for treatment of traumatic brain injury and related systems and methods
Assignee(s)REGENTS OF THE UNIVERSITY OF MINNESOTA, AURORA CONCUSSION THERAPY SYSTEMS